Bristol Myers Squibb to Present at J.P. Morgan’s 41st Annual Healthcare Conference
January 03 2023 - 7:05AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will present at J.P. Morgan’s 41st Annual Healthcare
Conference on Monday, January 9, 2023. Giovanni Caforio, M.D.,
Board Chair and Chief Executive Officer will make a formal
presentation and answer questions about the company at 7:30 a.m.
PST/10:30 a.m. EST.
The event will be webcast simultaneously at
http://investor.bms.com with materials related to the presentation
available at the start of the live webcast. A replay and archived
edition of the presentation will be available following the
event.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230103005011/en/
Bristol Myers Squibb
Media: media@bms.com
Investor Relations: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024